Profiting from the Pandemic: Will Pharmaceutical Giants Use Patents to Limit Access to COVID Drugs? скачать в хорошем качестве

Profiting from the Pandemic: Will Pharmaceutical Giants Use Patents to Limit Access to COVID Drugs?

As the number of confirmed COVID-19 cases worldwide approaches 4 million and the pandemic could be with us for months or years, we look at who can access drugs like remdesivir, being developed by pharmaceutical giant Gilead, which has the patent for the drug and is poised to make massive profits. We look at how much drugs like remdesivir will cost, and who can access them, with writer Achal Prabhala, coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa. #DemocracyNow Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: https://democracynow.org Please consider supporting independent media by making a donation to Democracy Now! today: https://democracynow.org/donate FOLLOW DEMOCRACY NOW! ONLINE: YouTube:    / democracynow   Facebook:   / democracynow   Twitter:   / democracynow   Instagram:   / democracynow   SoundCloud:   / democracynow   iTunes: https://itunes.apple.com/podcast/demo... Daily Email Digest: https://democracynow.org/subscribe